Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-09-26Clinical Trial Update: Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005% [Phase 4]
A Phase 4 trial comparing bimatoprost 0.03% with travoprost 0.004% in patients already using latanoprost, completed with posted results.
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41 [Phase 3]
A Phase 3 clinical trial sponsored by Alcon Research evaluating an intraocular pressure-lowering therapy for open-angle glaucoma and ocular …
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma [Phase 3]
A Phase 3 study compared travoprost 0.004% to latanoprost 0.005% in patients with chronic angle-closure glaucoma to evaluate safety and effi…
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients [Phase 2]
A Phase II safety and efficacy trial evaluating a glaucoma therapy in open-angle glaucoma or ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) [Phase 3]
A Phase 3 head-to-head trial comparing Travoprost 0.004% with Latanoprost 0.005% in open-angle glaucoma and ocular hypertension has complete…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT) [Phase 3]
A Phase 3 study comparing Travatan (travoprost) to Xalcom over six weeks evaluated safety and efficacy in adults with open-angle glaucoma or…
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98 [Phase 3]
Phase 3 trial in Japanese subjects evaluating IOP lowering in open-angle glaucoma or ocular hypertension, sponsored by Alcon Research; study…
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase III clinical trial of brimonidine tartrate ophthalmic solution 0.15% in open-angle glaucoma or ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension [Phase 4]
Phase 4 trial update investigating the mechanism of action of Travatan 0.004% in people with glaucoma or ocular hypertension. The study stat…
-
CLINICAL_TRIALS research · 2008-08-05Clinical Trial Update: Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69 [Phase 3]
Phase 3 clinical trial update for an intraocular pressure-lowering therapy in open-angle glaucoma and ocular hypertension; the study is comp…
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70 [Phase 3]
A Phase 3 clinical trial evaluating an intraocular pressure-lowering therapy for open-angle glaucoma and ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2008-07-29Clinical Trial Update: Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 2]
A Phase 2 dose-response study of AL-37807 ophthalmic solution in open-angle glaucoma or ocular hypertension has been completed.
-
FDA approval · 2008-06-27FDA Approved: BETAXOLOL HYDROCHLORIDE — Original Application (KVK-TECH, INC.)
FDA approves Betaxolol hydrochloride from KVK-Tech as an original ANDA product for the treatment of open-angle glaucoma and ocular hypertens…
-
CLINICAL_TRIALS trial_result · 2008-05-09Clinical Trial Update: Intraocular Pressure Accuracy and Variability of the Barraquer Tonometer [NA]
This clinical trial update assesses the accuracy and variability of the Barraquer Tonometer in measuring intraocular pressure.
-
FDA approval · 2008-05-08FDA Approved: BETOPTIC S — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for BETOPTIC S (betaxolol hydrochloride) from Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2008-05-08Clinical Trial Update: Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs [Phase 4]
This Phase 4 trial evaluated three adjunctive treatments (brimonidine purite, dorzolamide, and brinzolamide) added to prostaglandin analogs …
-
FDA approval · 2008-04-30FDA Approved: TIMOLOL MALEATE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original ANDA for timolol maleate from Rising Pharma Holdings, Inc., confirming a generic timolol maleate product is author…
-
CLINICAL_TRIALS trial_result · 2008-04-24Clinical Trial Update: Tolerability, Safety and Efficacy of SAD448 in Subjects With Ocular Hypertension [Phase 1]
Phase 1 study evaluating tolerability, safety, and preliminary efficacy of SAD448 in subjects with ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2008-04-22Clinical Trial Update: A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension [Phase 2]
This document reports the completion of a Phase II clinical trial evaluating AL-37807 for open-angle glaucoma and ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2008-04-07Clinical Trial Update: Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension. [Phase 4]
Phase 4 trial evaluating the efficacy and safety of Xalatan (latanoprost) compared with usual care in patients with open-angle glaucoma or o…
-
CLINICAL_TRIALS trial_result · 2008-04-03Clinical Trial Update: Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 2]
Phase 2 trial evaluating safety and efficacy of bimatoprost in ethnically Japanese patients with open-angle glaucoma or ocular hypertension;…
-
CLINICAL_TRIALS trial_result · 2008-04-03Clinical Trial Update: Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension [Phase 2]
This entry notes the completion of a Phase 2 trial assessing the safety and efficacy of different once-daily formulations of bimatoprost in …
-
CLINICAL_TRIALS trial_result · 2008-04-03Clinical Trial Update: Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients [Phase 3]
Phase 3 trial update evaluating the safety of Brimonidine/Timolol fixed combination in glaucoma and ocular hypertension. The trial status is…
-
CLINICAL_TRIALS trial_result · 2008-04-03Clinical Trial Update: Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 safety and efficacy study of brimonidine in patients with glaucoma or ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2008-04-03Clinical Trial Update: Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [Phase 3]
This update summarizes the results of a Phase 3 trial evaluating the safety and efficacy of a fixed-dose combination of brimonidine and timo…